A. Adams

发表

Integrative epigenome-wide analysis demonstrates that DNA methylation may mediate genetic risk in inflammatory bowel disease

S. Heath, H. Drummond, E. Nimmo, 2016, Nature communications.

Waiting in the wings: RUNX3 reveals hidden depths of immune regulation with potential implications for inflammatory bowel disease

J. Nowak, J. Walkowiak, A. Adams, 2021, Scandinavian journal of immunology.

Analysis of Systemic Epigenetic Alterations in Inflammatory Bowel Disease: Defining Geographical, Genetic and Immune-Inflammatory influences on the Circulating Methylome

J. Satsangi, M. Vatn, J. Jahnsen, 2021, Journal of Crohn's & colitis.

Blood-based DNA methylation in Crohn's disease and severity of intestinal inflammation.

J. Satsangi, R. Kalla, A. Adams, 2019, Translational gastroenterology and hepatology.

Systemic inflammation in pre-clinical ulcerative colitis.

S. Heath, H. Drummond, C. Lees, 2021, Gastroenterology.

Unexpected Actors in Inflammatory Bowel Disease Revealed by Machine Learning from Whole-Blood Transcriptomic Data

J. Ostrowski, J. Nowak, J. Walkowiak, 2022, Genes.

Long-term temporal stability of peripheral blood DNA methylation alterations in patients with inflammatory bowel disease

J. Satsangi, W. D. de Jonge, G. D'Haens, 2022, bioRxiv.

Fecal microbiota profiles in treatment-naïve pediatric inflammatory bowel disease – associations with disease phenotype, treatment, and outcome

J. Satsangi, M. Vatn, J. Jahnsen, 2019, Clinical and experimental gastroenterology.

Maintenance therapy with infliximab or vedolizumab in IBD is not associated with increased SARS-CoV-2 seroprevalence: UK experience in the 2020 pandemic

J. Satsangi, P. Klenerman, R. Sadler, 2021, Gut.

Early management of acute severe UC in the biologics era: development and international validation of a prognostic clinical index to predict steroid response

J. Satsangi, S. Travis, O. Brain, 2022, Gut.

Characterisation of the Circulating Transcriptomic Landscape in Inflammatory Bowel Disease Provides Evidence for Dysregulation of Multiple Transcription Factors Including NFE2, SPI1, CEBPB, and IRF2

J. Satsangi, M. Vatn, J. Ostrowski, 2022, Journal of Crohn's & colitis.

Serum Calprotectin: A Novel Diagnostic and Prognostic Marker in Inflammatory Bowel Diseases

H. Drummond, E. Nimmo, J. Satsangi, 2016, The American Journal of Gastroenterology.

Integrative epigenome-wide analysis demonstrates that DNA methylation may mediate genetic risk in inflammatory bowel disease

Fredrik Dahl, S. Heath, H. Drummond, 2016, Nature Communications.

Two-stage Genome-wide Methylation Profiling in Childhood-onset Crohn's Disease Implicates Epigenetic Alterations at the VMP1/MIR21 and HLA Loci

H. Drummond, E. Nimmo, J. Satsangi, 2014, Inflammatory bowel diseases.

A Final Frontier in Environment-Genome Interactions? Integrated, Multi-Omic Approaches to Predictions of Non-Communicable Disease Risk

R. Purcell, A. Adams, Y. K. Lam, 2022, Frontiers in Genetics.

Promoter methylation of the MGAT3 and BACH2 genes correlates with the composition of the immunoglobulin G glycome in inflammatory bowel disease

H. Drummond, E. Nimmo, J. Satsangi, 2018, Clinical Epigenetics.

Mucosal Gene Transcript Signatures in Treatment Naïve Inflammatory Bowel Disease: A Comparative Analysis of Disease to Symptomatic and Healthy Controls in the European IBD-Character Cohort

J. Satsangi, M. Vatn, J. Jahnsen, 2022, Clinical and experimental gastroenterology.

Long-term Temporal Stability of Peripheral Blood DNA Methylation Profiles in Patients With Inflammatory Bowel Disease

J. Satsangi, W. D. de Jonge, G. D'Haens, 2022, Cellular and molecular gastroenterology and hepatology.

Immune cell-specific smoking-related expression characteristics are revealed by re-analysis of transcriptomes from the CEDAR cohort

J. Nowak, J. Walkowiak, A. Adams, 2022, Central-European journal of immunology.

Systematic Review and Meta-analysis of Peripheral Blood DNA Methylation Studies in Inflammatory Bowel Disease

J. Satsangi, W. D. de Jonge, G. D'Haens, 2022, Journal of Crohn's & colitis.

Decrease in uptake of SARS-CoV-2 vaccine in patients with inflammatory bowel disease on intravenous biological therapy

J. Satsangi, A. Adams, J. Wellens, 2022, The Lancet Gastroenterology & Hepatology.

Retinal nerve fibre layer thickness associates with phenylketonuria control and cognition

I. Grulkowski, J. Nowak, J. Walkowiak, 2020, Journal of Medical Genetics.

Genome-Wide Methylation Profiling in 229 Patients With Crohn’s Disease Requiring Intestinal Resection: Epigenetic Analysis of the Trial of Prevention of Post-operative Crohn’s Disease (TOPPIC)

R. Prescott, C. Lees, J. Satsangi, 2023, Cellular and molecular gastroenterology and hepatology.

The prevalence and transcriptional activity of the mucosal microbiota of ulcerative colitis patients

S. Heath, H. Drummond, C. Lees, 2018, Scientific Reports.

Defining interactions between the genome, epigenome, and the environment in inflammatory bowel disease: progress and prospects.

J. Satsangi, H. Uhlig, J. Nowak, 2023, Gastroenterology.

Title: Single-cell characterization of peripheral blood mononuclear cells from Crohn’s disease patients on vedolizumab Short title: PBMC characterization of CD patients on VDZ

J. Satsangi, G. D'Haens, M. Mannens, 2023 .

Determinants of uptake of a third dose of SARS-CoV-2 vaccines in patients with inflammatory bowel disease

J. Satsangi, J. Lindsay, A. Adams, 2022, The Lancet Gastroenterology & Hepatology.

Discovery of a simple two-gene expression biomarker in whole blood predictive of the need for treatment escalation in inflammatory bowel disease

J. Satsangi, J. Halfvarson, R. Kalla, 2021, medRxiv.

Altered DNA methylation within DNMT3A, AHRR, LTA/TNF loci mediates the effect of smoking on inflammatory bowel disease

E. Theodoratou, R. Kalla, G. Ho, 2024, Nature communications.